Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Marchetti

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
AIDS Reviews|September 20, 2017
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?Valentina Svicher, Giulia Marchetti, Adrianna Ammassari, et al.
Open Forum Infectious Diseases|October 2, 2020
Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?Camilla Tincati, Debora Mondatore, Francesca Bai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2009
The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic optionsLidia Gazzola, Camilla Tincati, Giusi Maria Bellistrì, et al.
AIDS (London, England)|October 30, 2024
Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIVMatteo Augello, Valeria Bono, Roberta Rovito, et al.
Journal of Translational Medicine|May 7, 2024
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approachGiorgio Montesi, Matteo Augello, Jacopo Polvere, et al.
Journal of Visualized Experiments : Jove|June 23, 2011
Sequencing of bacterial microflora in peripheral blood: our experience with HIV-infected patientsEsther Merlini, Giusi M Bellistri, Camilla Tincati, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 13, 2008
Effective nocturnal oxygen therapy increases circulating level of tumor necrosis factor-alpha in heart failureStefano Guzzetti, Camilla Fundarò, Marica Pecis, et al.
AIDS (London, England)|May 18, 2023
Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infectionMatteo Augello, Valeria Bono, Roberta Rovito, et al.
Frontiers in Immunology|November 16, 2020
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of IllnessCamilla Tincati, E Stefania Cannizzo, Mauro Giacomelli, et al.
Jac-Antimicrobial Resistance|March 6, 2025
Switching from intravenous to oral antibiotic therapy in the treatment of infective endocarditis: a case series and literature review of real-world dataLorenzo Brando Lundgren, Lorenzo Albertini, Anna De Bona, et al.
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
AIDS Reviews|September 20, 2017
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?Valentina Svicher, Giulia Marchetti, Adrianna Ammassari, et al.
Open Forum Infectious Diseases|October 2, 2020
Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?Camilla Tincati, Debora Mondatore, Francesca Bai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2009
The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic optionsLidia Gazzola, Camilla Tincati, Giusi Maria Bellistrì, et al.
AIDS (London, England)|October 30, 2024
Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIVMatteo Augello, Valeria Bono, Roberta Rovito, et al.
Journal of Translational Medicine|May 7, 2024
Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approachGiorgio Montesi, Matteo Augello, Jacopo Polvere, et al.
Journal of Visualized Experiments : Jove|June 23, 2011
Sequencing of bacterial microflora in peripheral blood: our experience with HIV-infected patientsEsther Merlini, Giusi M Bellistri, Camilla Tincati, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 13, 2008
Effective nocturnal oxygen therapy increases circulating level of tumor necrosis factor-alpha in heart failureStefano Guzzetti, Camilla Fundarò, Marica Pecis, et al.
AIDS (London, England)|May 18, 2023
Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infectionMatteo Augello, Valeria Bono, Roberta Rovito, et al.
Frontiers in Immunology|November 16, 2020
Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of IllnessCamilla Tincati, E Stefania Cannizzo, Mauro Giacomelli, et al.
Jac-Antimicrobial Resistance|March 6, 2025
Switching from intravenous to oral antibiotic therapy in the treatment of infective endocarditis: a case series and literature review of real-world dataLorenzo Brando Lundgren, Lorenzo Albertini, Anna De Bona, et al.
Pageof 19